Xuan Qu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xuan Qu has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Albert H. Kim
Department of Neurosurgery, Washington University School of Medicine, St. Louis, Missouri, USA
2 shared publications Diane D. Mao
Taylor Family Department of Neurosurgery, Washington University School of Medicine, St. Louis, USA
2 shared publicationsHao Chen
Department of Genetics, Washington University School of Medicine, St. Louis, USA
2 shared publications- Hiroko Yano
Taylor Family Department of Neurosurgery, Washington University School of Medicine, St. Louis, USA
2 shared publications - Ting Wang
Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA
2 shared publications Afshin Salehi
Department of Neurological Surgery, Washington University School of Medicine, St. Louis, USA
1 shared publication
Latest Publications
- Open Access
- 7 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
INSM1 governs a neuronal progenitor state that drives glioblastoma in a human stem cell model
Glioblastoma is a lethal brain cancer marked by functional plasticity driven by tumor cell-intrinsic mutations and their interplay with developmental programs. To investigate how canonical glioblastoma mutations promote functional plasticity, we have developed an isogenic human neural stem cell (NSC) model of glioblastoma by sequential addition of TERT promoter, TP53 , and PDGFRA point mutations. TP53 loss-of-function increases TERT expression during serial mutagenesis, but only triple mutant NSCs reliably form lethal brain tumors in vivo that recapitulate glioblastoma. Tumor cell evolution triggers stress-related metabolic changes and transitions toward a neuronal progenitor network driven by transcription factor INSM1. INSM1 is highly expressed in human glioblastoma tumors and, during cortical development, in intermediate progenitor cells, which give rise to neurons. Remarkably, INSM1 knockdown in triple mutant NSCs and primary glioblastoma cells disrupts oncogenic gene expression and function and inhibits the in vivo tumorigenicity of triple mutant NSCs, highlighting the functional importance of an intermediate progenitor cell-like cell state in glioblastoma pathogenesis.
- 7 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessINSM1 governs a neuronal progenitor state that drives glioblastoma in a human stem cell model
Glioblastoma is a lethal brain cancer marked by functional plasticity driven by tumor cell-intrinsic mutations and their interplay with developmental programs. To investigate how canonical glioblastoma mutations promote functional plasticity, we have developed an isogenic human neural stem cell (NSC) model of glioblastoma by sequential addition of TERT promoter, TP53 , and PDGFRA point mutations. TP53 loss-of-function increases TERT expression during serial mutagenesis, but only triple mutant NSCs reliably form lethal brain tumors in vivo that recapitulate glioblastoma. Tumor cell evolution triggers stress-related metabolic changes and transitions toward a neuronal progenitor network driven by transcription factor INSM1. INSM1 is highly expressed in human glioblastoma tumors and, during cortical development, in intermediate progenitor cells, which give rise to neurons. Remarkably, INSM1 knockdown in triple mutant NSCs and primary glioblastoma cells disrupts oncogenic gene expression and function and inhibits the in vivo tumorigenicity of triple mutant NSCs, highlighting the functional importance of an intermediate progenitor cell-like cell state in glioblastoma pathogenesis.
- Open Access
- 1 August 2025
- Published by Wolters Kluwer Health in JU Open Plus
- Vol. 3 (8)
Self-Concocted Mixture of Liquid Oral Tadalafil Resulting in Ischemic Priapism: A Cautionary Tale
Background: Priapism, particularly ischemic priapism, is a medical emergency that requires prompt intervention to prevent permanent erectile dysfunction. Both prescription and recreational drugs have been implicated in its cause. This case highlights the consequences of intracavernous injection of a self-made mixture of crushed oral tadalafil after failure of oral tadalafil to induce an erection. Case Presentation: A 57-year-old male with a history of major depressive disorder, attention deficit hyperactivity disorder, and erectile dysfunction presented to the emergency department with a painful erection lasting approximately 36 hours. After oral tadalafil failed to achieve an erection, he crushed another tablet, mixed it with water, and injected it intracavernously. This caused a sustained, painful erection. The patient attempted various techniques, including masturbation and ice packs, but the erection persisted. On arrival at the emergency department, a corporal blood gas analysis confirmed ischemia. Initial bedside aspiration and phenylephrine injection offered minimal relief, and he opted for distal shunting after further discussion. The procedure successfully achieved detumescence. Conclusions: This case underscores the risks accompanying improper use of erectile dysfunction treatments, specifically, when oral tadalafil is administered intracavernously. Priapism resulting from such usage caused prolonged ischemia, requiring invasive procedures for resolution. This highlights the rare adverse reaction of tadalafil through intracavernous administration, the importance for thorough patient education, and proper guidance when prescribing treatments for erectile dysfunction to prevent potentially devastating complications.
- 1 August 2025
- Published by Wolters Kluwer Health in JU Open Plus
- Vol. 3 (8)
Open AccessSelf-Concocted Mixture of Liquid Oral Tadalafil Resulting in Ischemic Priapism: A Cautionary Tale
Background: Priapism, particularly ischemic priapism, is a medical emergency that requires prompt intervention to prevent permanent erectile dysfunction. Both prescription and recreational drugs have been implicated in its cause. This case highlights the consequences of intracavernous injection of a self-made mixture of crushed oral tadalafil after failure of oral tadalafil to induce an erection. Case Presentation: A 57-year-old male with a history of major depressive disorder, attention deficit hyperactivity disorder, and erectile dysfunction presented to the emergency department with a painful erection lasting approximately 36 hours. After oral tadalafil failed to achieve an erection, he crushed another tablet, mixed it with water, and injected it intracavernously. This caused a sustained, painful erection. The patient attempted various techniques, including masturbation and ice packs, but the erection persisted. On arrival at the emergency department, a corporal blood gas analysis confirmed ischemia. Initial bedside aspiration and phenylephrine injection offered minimal relief, and he opted for distal shunting after further discussion. The procedure successfully achieved detumescence. Conclusions: This case underscores the risks accompanying improper use of erectile dysfunction treatments, specifically, when oral tadalafil is administered intracavernously. Priapism resulting from such usage caused prolonged ischemia, requiring invasive procedures for resolution. This highlights the rare adverse reaction of tadalafil through intracavernous administration, the importance for thorough patient education, and proper guidance when prescribing treatments for erectile dysfunction to prevent potentially devastating complications.
- Open Access
- 13 May 2025
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 35 (6) , 1456-1471
Charting the regulatory landscape of TP53 on transposable elements in cancer
The relationship between TP53 and transposable elements (TEs) has been obscure. Given the important role of TEs in oncogenesis, a comprehensive profiling of TE expression dynamics under the regulation of TP53 provides valuable resources for more clarity in TP53's roles in cancer. In this study, we characterized the TE transcriptomic landscape using long-read RNA-seq and short-read RNA-seq in three cancer cell lines varying only inTP53genetic status. To identify transcripts that use TEs as potential promoters, we developed a computational pipeline, TEProf3, and identified in total 1942 transcripts with high confidence. Among these TE-derived transcripts, 239 are activated by TP53 and 221 are repressed by TP53. These TP53-responsive TE-derived transcripts are mainly driven by members of the ERV and LINE families. Following knockdown of wild-type (WT) TP53 expression, rescuing WT TP53 expression allows for partial recovery of the TE expression profile observed in the context of chronic TP53 expression. TP53 mutations R175H and R273H manifest their oncogenic characteristic partially through activating TE promoters in a cell type–specific manner. Lastly, we identified important sequence motifs that help govern the interactions between TEs and TP53, where TP53 activates TEs with TP53 binding motifs through direct binding and represses TEs indirectly via other pathways. Overall, we present a comprehensive profiling of the impact of TP53 on the activity of TE-derived promoters in isogenic cancer cell lines and provide a high-confidence TE expression atlas of TE promoters that are direct and indirect targets of TP53.
- 13 May 2025
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 35 (6) , 1456-1471
Open AccessCharting the regulatory landscape of TP53 on transposable elements in cancer
The relationship between TP53 and transposable elements (TEs) has been obscure. Given the important role of TEs in oncogenesis, a comprehensive profiling of TE expression dynamics under the regulation of TP53 provides valuable resources for more clarity in TP53's roles in cancer. In this study, we characterized the TE transcriptomic landscape using long-read RNA-seq and short-read RNA-seq in three cancer cell lines varying only inTP53genetic status. To identify transcripts that use TEs as potential promoters, we developed a computational pipeline, TEProf3, and identified in total 1942 transcripts with high confidence. Among these TE-derived transcripts, 239 are activated by TP53 and 221 are repressed by TP53. These TP53-responsive TE-derived transcripts are mainly driven by members of the ERV and LINE families. Following knockdown of wild-type (WT) TP53 expression, rescuing WT TP53 expression allows for partial recovery of the TE expression profile observed in the context of chronic TP53 expression. TP53 mutations R175H and R273H manifest their oncogenic characteristic partially through activating TE promoters in a cell type–specific manner. Lastly, we identified important sequence motifs that help govern the interactions between TEs and TP53, where TP53 activates TEs with TP53 binding motifs through direct binding and represses TEs indirectly via other pathways. Overall, we present a comprehensive profiling of the impact of TP53 on the activity of TE-derived promoters in isogenic cancer cell lines and provide a high-confidence TE expression atlas of TE promoters that are direct and indirect targets of TP53.
- Open Access
- 3 November 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-16
Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma
The pluripotency transcription factor SOX2 is essential for the maintenance of glioblastoma stem cells (GSC), which are thought to underlie tumor growth, treatment resistance, and recurrence. To understand how SOX2 is regulated in GSCs, we utilized a proteomic approach and identified the E3 ubiquitin ligase TRIM26 as a direct SOX2-interacting protein. Unexpectedly, we found TRIM26 depletion decreased SOX2 protein levels and increased SOX2 polyubiquitination in patient-derived GSCs, suggesting TRIM26 promotes SOX2 protein stability. Accordingly, TRIM26 knockdown disrupted the SOX2 gene network and inhibited both self-renewal capacity as well as in vivo tumorigenicity in multiple GSC lines. Mechanistically, we found TRIM26, via its C-terminal PRYSPRY domain, but independent of its RING domain, stabilizes SOX2 protein by directly inhibiting the interaction of SOX2 with WWP2, which we identify as a bona fide SOX2 E3 ligase in GSCs. Our work identifies E3 ligase competition as a critical mechanism of SOX2 regulation, with functional consequences for GSC identity and maintenance.
- 3 November 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-16
Open AccessCompetitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma
The pluripotency transcription factor SOX2 is essential for the maintenance of glioblastoma stem cells (GSC), which are thought to underlie tumor growth, treatment resistance, and recurrence. To understand how SOX2 is regulated in GSCs, we utilized a proteomic approach and identified the E3 ubiquitin ligase TRIM26 as a direct SOX2-interacting protein. Unexpectedly, we found TRIM26 depletion decreased SOX2 protein levels and increased SOX2 polyubiquitination in patient-derived GSCs, suggesting TRIM26 promotes SOX2 protein stability. Accordingly, TRIM26 knockdown disrupted the SOX2 gene network and inhibited both self-renewal capacity as well as in vivo tumorigenicity in multiple GSC lines. Mechanistically, we found TRIM26, via its C-terminal PRYSPRY domain, but independent of its RING domain, stabilizes SOX2 protein by directly inhibiting the interaction of SOX2 with WWP2, which we identify as a bona fide SOX2 E3 ligase in GSCs. Our work identifies E3 ligase competition as a critical mechanism of SOX2 regulation, with functional consequences for GSC identity and maintenance.